Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acacia Research (ACTG) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Acacia Research (ACTG) over the last 9 years, with Q3 2025 value amounting to $301.8 million.

  • Acacia Research's Cash & Equivalents fell 1618.39% to $301.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $301.8 million, marking a year-over-year decrease of 1618.39%. This contributed to the annual value of $273.9 million for FY2024, which is 1946.86% down from last year.
  • Acacia Research's Cash & Equivalents amounted to $301.8 million in Q3 2025, which was down 1618.39% from $316.7 million recorded in Q2 2025.
  • In the past 5 years, Acacia Research's Cash & Equivalents ranged from a high of $438.8 million in Q1 2024 and a low of $180.2 million during Q1 2021
  • Its 5-year average for Cash & Equivalents is $305.4 million, with a median of $301.8 million in 2025.
  • Per our database at Business Quant, Acacia Research's Cash & Equivalents skyrocketed by 9238.88% in 2021 and then plummeted by 3801.56% in 2025.
  • Quarter analysis of 5 years shows Acacia Research's Cash & Equivalents stood at $308.9 million in 2021, then dropped by 6.85% to $287.8 million in 2022, then increased by 18.17% to $340.1 million in 2023, then decreased by 19.47% to $273.9 million in 2024, then grew by 10.19% to $301.8 million in 2025.
  • Its Cash & Equivalents stands at $301.8 million for Q3 2025, versus $316.7 million for Q2 2025 and $272.0 million for Q1 2025.